Celator Pharmaceuticals, Inc. Appoints Michael R. Dougherty to Board of Directors
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Celator Pharmaceuticals, Inc., a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the appointment of Michael R. Dougherty to its Board of Directors, effective immediately.
“Mike is a highly skilled life sciences veteran with insight and expertise in strategy, finance and operations,” said Scott Jackson, chief executive officer of Celator. “These skills will prove extremely valuable as we continue to build the company.”
Help employers find you! Check out all the jobs and post your resume.
Celator Pharmaceuticals, Inc., a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the appointment of Michael R. Dougherty to its Board of Directors, effective immediately.
“Mike is a highly skilled life sciences veteran with insight and expertise in strategy, finance and operations,” said Scott Jackson, chief executive officer of Celator. “These skills will prove extremely valuable as we continue to build the company.”
Help employers find you! Check out all the jobs and post your resume.